Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting

Cisplatin is commonly recognized as a DNA-damaging drug; however, its versatile antitumor effects have been demonstrated to extend beyond this narrow functional attribute. The present study determined how cisplatin regulates alternative pathways and transcription factors to exert its additional anti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncol Lett
Egile Nagusiak: Kuo, Jinn-Rung, Shang, Hung-Sheng, Ho, Chun-Te, Lai, Kun-Goung, Liu, Tsan-Zon, Chen, Yin-Ju, Chiou, Jeng-Fong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2016
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5104157/
https://ncbi.nlm.nih.gov/pubmed/27895723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5181
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak